Despite a recent survey that showed most doctors didn't know about Afrezza, Jefferies is still bullish on the stock as of a recent rating. However, the top ranked analysts are saying Hold or Sell: http://ift.tt/1HauXEc I guess it depends how much you're willing to bet on a drug.
Investing in MannKind because of Afrezza?
Aucun commentaire:
Enregistrer un commentaire